Related references
Note: Only part of the references are listed.Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
Markus Hilty et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Outcomes of Children With Enterobacteriaceae Bacteremia With Reduced Susceptibility to Ceftriaxone: Do the Revised Breakpoints Translate to Improved Patient Outcomes?
Pranita D. Tamma et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
P. N. A. Harris et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Clinical Laboratory Detection of AmpC β-Lactamase Does It Affect Patient Outcome?
Kenneth H. Rand et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing Enterobacteriaceae
Silke Polsfuss et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis
S. Peter-Getzlaff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Emerging carbapenemases: a global perspective
Timothy R. Walsh
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Risk factors and clinical features of infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae
Yoon Soo Park et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Cephalosporin MIC Distribution of Extended-Spectrum-β-Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species
Peggy C. Kohner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase:: Implications for antibiotic use
Sang-Ho Choi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis
Wonkeun Song et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests
George A. Jacoby et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance
Amber J. Schmidtke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis
PE Coudron
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli
T Yagi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Bloodstream infections caused by Enterobacter species:: Predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2004)
Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase
CI Kang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?
DM Livermore et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae
H Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Serratia bacteremia in a large university hospital:: Trends in antibiotic resistance during 10 years and implications for antibiotic use
SH Choi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species
SE Cosgrove et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
KS Kaye et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
